La Jolla Pharma Drug Patent Portfolio

La Jolla Pharma owns 1 orange book drug protected by 11 US patents Given below is the list of La Jolla Pharma's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11219662 Methods for treating hypotension in a patient that has received an ACE inhibitor by administering angiotensin II 06 Jan, 2037
Active
US10028995 Angiotensin II alone or in combination for the treatment of hypotension 18 Dec, 2034
Active
US10493124 Angiotensin II alone or in combination for the treatment of hypotension 18 Dec, 2034
Active
US11096983 Angiotensin II alone or in combination for the treatment of hypotension 18 Dec, 2034
Active
US11559559 Angiotensin II alone or in combination for the treatment of hypotension 18 Dec, 2034
Active
US9220745 Angiotensin II alone or in combination for the treatment of hypotension 18 Dec, 2034
Active
US9572856 Method of treating low blood pressure 18 Jul, 2031
Active
US10335451 Method of treating low blood pressure 16 Dec, 2029
Active
US10500247 Method of treating low blood pressure 16 Dec, 2029
Active
US10548943 Method of treating low blood pressure 16 Dec, 2029
Active
US9867863 Method of treating low blood pressure 16 Dec, 2029
Active


Given below is the list of recent legal activities going on the following drug patents of La Jolla Pharma.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 04 Aug, 2023 US10548943
Payment of Maintenance Fee, 8th Year, Large Entity 29 Jun, 2023 US9220745
Payment of Maintenance Fee, 4th Year, Large Entity 12 Jun, 2023 US10500247
Payment of Maintenance Fee, 4th Year, Large Entity 05 Jun, 2023 US10493124
Sequence Moved to Public Database 24 Jan, 2023 US11559559
Recordation of Patent Grant Mailed 24 Jan, 2023 US11559559
Patent Issue Date Used in PTA Calculation 24 Jan, 2023 US11559559
Email Notification 05 Jan, 2023 US11559559
Issue Notification Mailed 04 Jan, 2023 US11559559
Payment of Maintenance Fee, 4th Year, Large Entity 03 Jan, 2023 US10335451
Dispatch to FDC 30 Dec, 2022 US11559559
Application Is Considered Ready for Issue 30 Dec, 2022 US11559559
Issue Fee Payment Received 15 Dec, 2022 US11559559
Issue Fee Payment Verified 15 Dec, 2022 US11559559
Sequence Forwarded to Pubs on Tape 30 Nov, 2022 US11559559


La Jolla Pharma's Family Patents

La Jolla Pharma drugs have patent protection in a total of 23 countries. It's US patent count contributes only to 37.7% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



La Jolla Pharma Drug List

Given below is the complete list of La Jolla Pharma's drugs and the patents protecting them.


1. Giapreza

Giapreza is protected by 12 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11219662 Methods for treating hypotension in a patient that has received an ACE inhibitor by administering angiotensin II 06 Jan, 2037
(12 years from now)
Active
US10028995 Angiotensin II alone or in combination for the treatment of hypotension 18 Dec, 2034
(10 years from now)
Active
US10493124 Angiotensin II alone or in combination for the treatment of hypotension 18 Dec, 2034
(10 years from now)
Active
US11096983 Angiotensin II alone or in combination for the treatment of hypotension 18 Dec, 2034
(10 years from now)
Active
US11559559 Angiotensin II alone or in combination for the treatment of hypotension 18 Dec, 2034
(10 years from now)
Active
US9220745 Angiotensin II alone or in combination for the treatment of hypotension 18 Dec, 2034
(10 years from now)
Active
US9572856 Method of treating low blood pressure 18 Jul, 2031
(6 years from now)
Active
US9572856 Method of treating low blood pressure 20 Nov, 2030
(6 years from now)
Active
US10335451 Method of treating low blood pressure 16 Dec, 2029
(5 years from now)
Active
US10500247 Method of treating low blood pressure 16 Dec, 2029
(5 years from now)
Active
US10548943 Method of treating low blood pressure 16 Dec, 2029
(5 years from now)
Active
US9867863 Method of treating low blood pressure 16 Dec, 2029
(5 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Giapreza's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List